Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
1,278
Sort by:
Global PCR & Real-time PCR Molecular Diagnostics Market Size study, by Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents and Consumables), By Application (Infectious Diseases Testing and Oncology Testing), By End-Users (Hospitals, Diagnostic Laboratories, Academic & Research Centers and Others) and Regional Forecasts 2020-2027
US$ 3,750.00
Global PCR & Real-time PCR Molecular Diagnostics Market is valued approximately USD 4.10 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.00% over the forecast peri...
October 2020
200 pages
Global Molecular Diagnostics Market, 2020-2026
US$ 3,000.00
The global molecular diagnostics market size was valued at $12,134.69 million in 2019 and is projected to reach $21,716.83 million by 2026, registering a CAGR of 8.67% from 2020 to 2026. The molecular...
March 2020
97 pages
2020 World Molecular Diagnostic Analyzer and Reagent Forecasts for 100 Tests: Americas, EMEA, APAC-A 68-Country Analysis-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities
US$ 45,000.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
March 2020
1850 pages
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology, By Application, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
The global molecular diagnostics market size is expected to reach USD 19.8 billion by 2026, according to a new report by Grand ... segment Based on test location, central laboratories led the market with the largest market share in 2018 owing to their established base in the remote ...
February 2020
185 pages
Molecular Diagnostics Global Market - Forecast to 2026
US$ 4,950.00
There is an emerging trend towards precision health in today’s world to enhance disease diagnosis, treatment, prevention and monitoring by using innovative diagnostic technologies with broader range a...
February 2020
539 pages
